Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
26 results
D1.370 - Clinical outcomes and quality of life improvement in children with moderate-to-severe atopic dermatitis and atopic multimorbidity treated with dupilumab
D1.362 - Exploratory Efficacy, Pharmacokinetics, Pharmacodynamics and Safety of YH35324, a Long-Acting high-affinity IgETrap-Fc protein, in Patients with Chronic Spontaneous Urticaria Refractory to Omalizumab
D1.363 - Efficacy and safety of Mepolizumab in treatment of eosinophilic granulomatosis with polyangiitis
D1.364 - Update on the Observed incidence of Anaphylaxis and Serum Sickness in Patients Receiving Omalizumab in a Canadian Tertiary Allergy/Asthma Clinic
D1.365 - ZL-1503: A Bispecific Antibody Targeting Inflammatory and Pruritogenic Pathways with a Prolonged Serum Half-life and Sustained Activity in Non-human Primates
D1.366 - Improvement Over Time in Specific Aspects of Quality of Life in Patients with Chronic Spontaneous Urticaria Treated with Omalizumab
D1.367 - Dupilumab for refractory pruritus in hematological and non-hematological malignancies – preliminary results
D1.368 - Anti-interleukin-5 treatment in patients with severe eosinophilic asthma provides consistent symptom control for at least 8 years
D1.369 - Characteristics of patients with severe asthma undergoing biological treatment at a reference center
D1.371 - Dupilumab for the treatment of refractory severe chronic spontaneous urticaria
D2.82 - Association between additional corticosteroid usage and Uncontrolled Severe Asthma: A Retrospective Study Using the China Regional Database
D2.83 - Correct Inhaler Technique as a Key Element of Asthma Management: Post-Education Evaluation of Patients' Knowledge
D2.84 - Heterogeneity of Elderly Asthma: a nationwide health and nutrition examination survey
D2.85 - Living a Normal Life with Asthma: Development of a Conceptual Model
D2.86 - Characteristics of Severe type 2 Asthma Patients in China: A Retrospective Observational Study
D2.87 - Disease Burden of Severe Asthma Patients Treated with Medium and High Doses of ICS: A Regional Database Analysis from China
D2.89 - Investigation of Asthma Characteristics in Women with Generalized Periodontitis and Polycystic Ovary Syndrome
D2.90 - Decrease in New-Onset Asthma During the COVID-19 Pandemic
D2.91 - Distribution of Patients with Asthma According to the New Immune Response Classification
D2.92 - Comparison of responsiveness to bronchodilators using the 2021 or 2005 ATS/ERS guidelines: bicenter retrospective study
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download